Development of therapeutic or preventative technologies for treatment or prevention of Pediatric Cancers and/or Rare Cancers.

The National Institutes of Health (NIH) is offering a Small Business Innovation Research (SBIR) opportunity focused on the development of therapeutic or preventative technologies for pediatric and rare cancers. This initiative aims to support innovative and disruptive solutions that address the urgent need for advancements in the prevention, diagnosis, and treatment of these cancers, which significantly lag behind other major cancer types due to smaller patient populations and challenging development pathways. The program will provide funding of up to $300,000 for a duration of 12 months, with an additional $6,500 available for Technical Assistance for Business Applications (TABA) if requested. Interested applicants must submit their proposals by September 26, 2025, and can find more information at the provided links.